Literature DB >> 30788974

Orbital Complications of Rhinosinusitis in the Adult Population: Analysis of Cases Presenting to a Tertiary Medical Center Over a 13-Year Period.

Aiman El Mograbi1,2, Amit Ritter1,2, Esmat Najjar1,2, Ethan Soudry1,2.   

Abstract

BACKGROUND: Orbital complications of rhinosinusitis in adults are scarcely discussed in the literature.
OBJECTIVE: To review our experience with the management of orbital complications of rhinosinusitis in the adult patient population and identify key factors in the characteristics and management of these patients.
DESIGN: Retrospective case series during the years 2004 to 2016 in a tertiary referral center including all patients with rhinosinusitis and orbital complications. MAIN OUTCOMES AND MEASURES: Severity of complications, risk factors, clinical, imaging and microbiological data, treatment outcomes.
RESULTS: Seventy patients were identified. Median age at diagnosis was 38 years. In 57%, complications were associated with acute rhinosinusitis and in 43% with chronic rhinosinusitis, most of whom had a history of previous sinus surgery. Thirty-five percent of patients received antibiotics prior to admission. The majority of the previously operated patients (61%) had some form of orbital wall dehiscence noted on imaging. Preseptal cellulitis was the most common complication (61.5%) encountered, followed by orbital cellulitis (23%), sub-periosteal abscess (11.5%), orbital abscess (3%), and cavernous sinus thrombosis (1.5%). Gram-positive bacteria were more commonly isolated from acute rhinosinusitis patients and gram-negative bacteria from chronic rhinosinusitis (CRS) patients. Complete recovery was noted in all patients, of whom 85% were managed conservatively. All, but 1 patient, with an abscess or cavernous sinus thrombosis required surgical drainage. Older age was the only risk factor identified for severe complications.
CONCLUSIONS: In contrast to the pediatric population, CRS is very common in adults with orbital complications of rhinosinusitis, with previous sinus surgery and orbital wall dehiscence being noticeably common. Older patients are at risk for more severe complications. Conservative treatment suffices in patients with preseptal and orbital cellulitis. In more advanced stages, surgical drainage is advocated with excellent results. Larger cohort studies are needed to further investigate this patient group.

Entities:  

Keywords:  adult patient; chronic rhinosinusitis; miscellaneous; orbital complications; otolaryngology; rhinology; rhinosinusitis; sinus surgery

Mesh:

Substances:

Year:  2019        PMID: 30788974     DOI: 10.1177/0003489419832624

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

1.  The efficacy of itraconazole, fluticasone and doxycycline in chronic rhinosinusitis.

Authors:  Seyyed Mostafa Hashemi; Seyed Mojtaba Abtahi Forooshani; Ali Borhani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-08-15

2.  Sinogenic Orbital Complications.

Authors:  Hans J Welkoborsky; Susanne Pitz; Sylvia Grass; Boris Breuer; Anja Pähler Vor der Holte; Oliver Bertram; Burkhard Wiechens
Journal:  Dtsch Arztebl Int       Date:  2022-01-21       Impact factor: 8.251

3.  To What Extent Can Orbital Cellulitis Emergency Aspect Influence the Diagnosis of Maxillary Sinus Lymphoma?

Authors:  Yousra Ajhoun; Ismail Aissa; Taoufik Abdellaoui; Yasmine Chaoui Roqai; Ilias Benchafai; Redouan Messaoudi; Rachid Zerrouk; Karim Reda; Abdelbarre Oubaaz
Journal:  Case Rep Ophthalmol Med       Date:  2020-04-08

Review 4.  Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020.

Authors:  Francesca Jaume; Meritxell Valls-Mateus; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-03       Impact factor: 4.806

5.  The Development of Glaucoma after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study.

Authors:  Siu-Fung Chau; Pei-Hsuan Wu; Chi-Chin Sun; Jing-Yang Huang; Chan-Wei Nien; Shun-Fa Yang; Ming-Chih Chou; Pei-Ting Lu; Hung-Chi Chen; Chia-Yi Lee
Journal:  Int J Environ Res Public Health       Date:  2019-11-13       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.